首页> 外文OA文献 >Therapeutic efficacy of combining pegylated liposomal doxorubicin and radiofrequency (RF) ablation: comparison between slow-drug-releasing, non-thermosensitive and fast-drug-releasing, thermosensitive nano-liposomes.

【2h】

Therapeutic efficacy of combining pegylated liposomal doxorubicin and radiofrequency (RF) ablation: comparison between slow-drug-releasing, non-thermosensitive and fast-drug-releasing, thermosensitive nano-liposomes.

机译：结合聚乙二醇化脂质体多柔比星和射频（RF）消融的治疗效果：缓释药物释放，非热敏释放和快速药物释放，热敏纳米脂质体之间的比较。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Alexander V Andriyanov; Erez Koren; Yechezkel Barenholz; S Nahum Goldberg;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Therapeutic efficacy of combined PEGylated liposomal doxorubicin and radiofrequency ablation: Comparing single and combined therapy in young and old mice [J] . Andriyanov Alexander V., Portnoy Emma, Koren Erez, Journal of Controlled Release: Official Journal of the Controlled Release Society . 2017,第期

机译：联合聚乙二醇化脂质体多柔比蛋白和射频消融的治疗疗效：比较青少年老鼠的单一和组合治疗
2. Pharmacokinetics, efficacy and toxicity of different pegylated liposomal doxorubicin formulations in preclinical models: is a conventional bioequivalence approach sufficient to ensure therapeutic equivalence of pegylated liposomal doxorubicin products? [J] . Rao N. V. S. Mamidi, Steve Weng, Susan Stellar, Cancer Chemotherapy and Pharmacology . 2010,第6期

机译：临床前模型中不同聚乙二醇化脂质体阿霉素制剂的药代动力学，功效和毒性：常规生物等效性方法是否足以确保聚乙二醇化脂质体阿霉素产品的治疗等效性？
3. Pharmacokinetics, efficacy and toxicity of different pegylated liposomal doxorubicin formulations in preclinical models: is a conventional bioequivalence approach sufficient to ensure therapeutic equivalence of pegylated liposomal doxorubicin products? [J] . Mamidi RN, Weng S, Stellar S, Cancer chemotherapy and pharmacology. . 2010,第6期

机译：在临床前模型中不同聚乙二醇化脂质体DOXORUBICIN制剂的药代动力学，疗效和毒性：是一种足以确保聚乙二醇化脂质体DOXORUBICIN产品的治疗当量的常规生物等效方法。
4. Enhanced therapeutic efficacy of bcl-2antisense oligonucleotide G3139 combined with sterically-stabilized liposomal doxorubicin [C] . D.Lopes de Menezes, N.Hudon, N.McIntosh, International symposium on controlled release of bioactive materials;Consumer and diversified products conference . 2000

机译：bcl-2反义寡核苷酸G3139与空间稳定的脂质体阿霉素联用可提高治疗效果
5. Pharmacokinetics, biodistribution, toxicity and therapeutic efficacy of liposomal doxorubicin formulations in mice. [D] . Charrois, Gregory John Robert. 2003

机译：脂质体阿霉素制剂在小鼠中的药代动力学，生物分布，毒性和治疗功效。
6. Therapeutic Efficacy of Combining PEGylated Liposomal Doxorubicin and Radiofrequency (RF) Ablation: Comparison between Slow-Drug-Releasing Non-Thermosensitive and Fast-Drug-Releasing Thermosensitive Nano-Liposomes [O] . Alexander V. Andriyanov, Erez Koren, Yechezkel Barenholz, -1

机译：聚乙二醇化脂质体阿霉素和射频消融治疗的疗效：缓释非热敏快释热敏纳米脂质体的比较
7. Phase III HEAT study adding lyso-thermosensitive liposomal doxorubicin to radiofrequency ablation in patients with unresectable hepatocellular carcinoma lesions [O] . Tak, Won Young, Lin, Shi-Ming, Wang, Yijun, 2018

机译：HEAT III期研究在无法切除的肝细胞癌病变患者中加入溶酶热敏感性脂质体阿霉素加射频消融

Therapeutic efficacy of combining pegylated liposomal doxorubicin and radiofrequency (RF) ablation: comparison between slow-drug-releasing, non-thermosensitive and fast-drug-releasing, thermosensitive nano-liposomes.

著录项

引文网络

相似文献

相关主题

期刊订阅